219 related articles for article (PubMed ID: 26960442)
41. Temporal corneal phacoemulsification combined with superior trabeculectomy: a controlled study.
Caprioli J; Park HJ; Weitzman M
Trans Am Ophthalmol Soc; 1996; 94():451-63; discussion 463-8. PubMed ID: 8981709
[TBL] [Abstract][Full Text] [Related]
42. Recurrence of treated ciliary body melanoma following trabeculectomy.
Tay E; Cree IA; Hungerford J; Franks W
Clin Exp Ophthalmol; 2009 Jul; 37(5):503-5. PubMed ID: 19624348
[TBL] [Abstract][Full Text] [Related]
43. Deep sclerectomy combined with trabeculectomy in pediatric glaucoma.
Feusier M; Roy S; Mermoud A
Ophthalmology; 2009 Jan; 116(1):30-8. PubMed ID: 19010550
[TBL] [Abstract][Full Text] [Related]
44. Effect of additive preoperative latanoprost treatment on the outcome of filtration surgery.
Berthold S; Pfeiffer N
Graefes Arch Clin Exp Ophthalmol; 2006 Aug; 244(8):1029-34. PubMed ID: 16341541
[TBL] [Abstract][Full Text] [Related]
45. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.
Fontana H; Nouri-Mahdavi K; Lumba J; Ralli M; Caprioli J
Ophthalmology; 2006 Jun; 113(6):930-6. PubMed ID: 16647135
[TBL] [Abstract][Full Text] [Related]
46. Ultrasonography and transillumination for uveal melanoma localisation in proton beam treatment planning.
Lu JE; Welch RJ; Mishra KK; Daftari IK; Park SS
Eye (Lond); 2019 Dec; 33(12):1904-1910. PubMed ID: 31278380
[TBL] [Abstract][Full Text] [Related]
47. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
Petrovic A; Bergin C; Schalenbourg A; Goitein G; Zografos L
Ophthalmology; 2014 Apr; 121(4):898-904. PubMed ID: 24405742
[TBL] [Abstract][Full Text] [Related]
48. Outcomes of proton therapy for the treatment of uveal metastases.
Kamran SC; Collier JM; Lane AM; Kim I; Niemierko A; Chen YL; MacDonald SM; Munzenrider JE; Gragoudas E; Shih HA
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1044-50. PubMed ID: 25442038
[TBL] [Abstract][Full Text] [Related]
49. [Results of treating uveal melanoma with proton beam radiation: 10-year follow-up].
Hamrouni Z; Levy C; Lumbroso L; D'Hermies F; Frau E; Mazal A; Delacroix S; Nauraye C; Dendale R; Schlienger P; Desjardins L
J Fr Ophtalmol; 2005 Oct; 28(8):833-9. PubMed ID: 16249762
[TBL] [Abstract][Full Text] [Related]
50. Neoadjuvant proton beam irradiation followed by transscleral resection of uveal melanoma in 106 cases.
Willerding GD; Cordini D; Moser L; Krause L; Foerster MH; Bechrakis NE
Br J Ophthalmol; 2016 Apr; 100(4):463-7. PubMed ID: 26224096
[TBL] [Abstract][Full Text] [Related]
51. Uveal melanoma: quantitative evaluation of diffusion-weighted MR imaging in the response assessment after proton-beam therapy, long-term follow-up.
Foti PV; Longo A; Reibaldi M; Russo A; Privitera G; Spatola C; Raffaele L; Salamone V; Farina R; Palmucci S; Musumeci A; Caltabiano R; Ragusa M; Mariotti C; Avitabile T; Milone P; Ettorre GC
Radiol Med; 2017 Feb; 122(2):131-139. PubMed ID: 27752969
[TBL] [Abstract][Full Text] [Related]
52. Trabeculectomy with brief exposure to mitomycin C.
Ben Simon GJ; Glovinsky Y
Clin Exp Ophthalmol; 2006 Nov; 34(8):765-70. PubMed ID: 17073899
[TBL] [Abstract][Full Text] [Related]
53. Secondary Enucleations for Uveal Melanoma: A 7-Year Retrospective Analysis.
Fabian ID; Tomkins-Netzer O; Stoker I; Arora AK; Sagoo MS; Cohen VM
Am J Ophthalmol; 2015 Dec; 160(6):1104-1110.e1. PubMed ID: 26344583
[TBL] [Abstract][Full Text] [Related]
54. Proton beam radiotherapy of diffuse iris melanoma in 54 patients.
Willerding GD; Cordini D; Hackl C; Karle B; Lakotka N; Foerster MH; Bechrakis NN; Heufelder J; Moser L; Joussen AM
Br J Ophthalmol; 2015 Jun; 99(6):812-6. PubMed ID: 25505288
[TBL] [Abstract][Full Text] [Related]
55. Suspected vitreous seeding of uveal melanoma: relevance of diagnostic vitrectomy.
Metz CH; Bornfeld N; Metz KA; Gök M
Br J Ophthalmol; 2016 May; 100(5):660-4. PubMed ID: 26359338
[TBL] [Abstract][Full Text] [Related]
56. [Molteno implant and refractory glaucoma. Evaluation of postoperative IOP control and complications with a modified surgical procedure].
Hamard P; Loison-Dayma K; Kopel J; Hamard H; Baudouin C
J Fr Ophtalmol; 2003 Jan; 26(1):15-23. PubMed ID: 12610405
[TBL] [Abstract][Full Text] [Related]
57. Primary trabeculectomy with mitomycin C: safety and efficacy at 2 years.
Lusthaus JA; Kubay O; Karim R; Wechsler D; Booth F
Clin Exp Ophthalmol; 2010 Dec; 38(9):831-8. PubMed ID: 20572827
[TBL] [Abstract][Full Text] [Related]
58. Filtering bleb structure associated with long-term intraocular pressure control after amniotic membrane-assisted trabeculectomy.
Nakamura M; Naka M; Tatsumi Y; Nagai-Kusuhara A; Kanamori A; Yamada Y; Negi A
Curr Eye Res; 2012 Mar; 37(3):239-50. PubMed ID: 22335812
[TBL] [Abstract][Full Text] [Related]
59. Intraocular inflammation after proton beam irradiation for uveal melanoma.
Lumbroso L; Desjardins L; Levy C; Plancher C; Frau E; D'Hermies F; Schlienger P; Mammar H; Delacroix S; Nauraye C; Ferrand R; Desblancs C; Mazal A; Asselain B
Br J Ophthalmol; 2001 Nov; 85(11):1305-8. PubMed ID: 11673294
[TBL] [Abstract][Full Text] [Related]
60. Proton therapy of iris melanoma with 50 CGE : Influence of target volume on clinical outcome.
Riechardt AI; Karle B; Cordini D; Heufelder J; Budach V; Joussen AM; Gollrad J
Strahlenther Onkol; 2017 Nov; 193(11):943-950. PubMed ID: 28631017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
